Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
404.37
+4.16 (1.04%)
At close: Jun 24, 2025, 4:00 PM
404.50
+0.13 (0.03%)
After-hours: Jun 24, 2025, 7:41 PM EDT
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $152.65 billion as of June 24, 2025. Its market cap has decreased by -30.49% in one year.
Market Cap
152.65B
Enterprise Value
180.96B
1-Year Change
-30.49%
Ranking
Category
Stock Price
$404.37
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $152.65B, an increase of 5,533.36%. That is a compound annual growth rate of 16.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 23, 2025 | 151.08B | -24.08% |
Dec 31, 2024 | 198.99B | -2.97% |
Dec 29, 2023 | 205.08B | -5.04% |
Dec 30, 2022 | 215.98B | -17.86% |
Dec 31, 2021 | 262.92B | 42.43% |
Dec 31, 2020 | 184.61B | 41.71% |
Dec 31, 2019 | 130.27B | 44.60% |
Dec 31, 2018 | 90.09B | 18.32% |
Dec 29, 2017 | 76.14B | 36.60% |
Dec 30, 2016 | 55.74B | -1.54% |
Dec 31, 2015 | 56.61B | 12.95% |
Dec 31, 2014 | 50.12B | 24.56% |
Dec 31, 2013 | 40.24B | 75.14% |
Dec 31, 2012 | 22.97B | 35.05% |
Dec 30, 2011 | 17.01B | -22.69% |
Dec 31, 2010 | 22.00B | 13.00% |
Dec 31, 2009 | 19.47B | 36.01% |
Dec 31, 2008 | 14.32B | -40.91% |
Dec 31, 2007 | 24.23B | 238.55% |
Dec 29, 2006 | 7.16B | 46.40% |
Dec 30, 2005 | 4.89B | 1.23% |
Dec 31, 2004 | 4.83B | 17.69% |
Dec 31, 2003 | 4.10B | 24.71% |
Dec 31, 2002 | 3.29B | -22.44% |
Dec 31, 2001 | 4.24B | -20.79% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 690.36B |
Johnson & Johnson | 364.76B |
AbbVie | 325.78B |
Novo Nordisk | 309.67B |
UnitedHealth Group | 273.95B |
Abbott Laboratories | 231.21B |
Novartis AG | 229.25B |
AstraZeneca | 218.15B |